Skip to main content
CHRS logo

CHRS · Coherus Oncology, Inc. · Analyst Estimates

Track CHRS — free
$1.15 -0.07 (-5.37%) At close · Oct 1
Market Cap
$180.77M
Shares
154.50M
Volume · Oct 1 709.41K Avg daily vol (3M) 1.11M

Analyst Estimates

Compare analyst forecasts for Coherus Oncology, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 12:23 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.87
-0.855
-0.84
—
-0.745
-0.745
-0.745
-0.79
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
0
1
0
Revenue
USD
Publication date not stated
58617000
60806190
65750000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.65
-0.63
-0.61
—
-1.02
-1.02
-1.02
-0.81
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
78765000
100366910
117000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.21
-0.21
-0.21
—
-0.225
-0.225
-0.225
-0.25
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
2
0
Revenue
USD
Publication date not stated
14941000
16011500
17428000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.22
-0.205
-0.19
—
-0.15
-0.15
-0.15
-0.14
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
0
1
0
Revenue
USD
Publication date not stated
16500000
18297000
21705000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —
Key facts CIK 1512762 CUSIP 19249H103 13F (30d) 4 filings 4 filers Visit website Investor relations